The introduction of nicotinamide as being a nicotine substitution in e-cigarette and smokeless solutions signifies a major regulatory challenge for that FDA. Nicotinamide does not have nicotinic receptor agonist activity and is understood to act as a sedative at high dosages6. The claims produced by Nicotine River, ECBlend, along with other vendors… Read More